Angiotensin Converting Enzyme 90Â kDa isoform: Biomarker for diagnosis of preeclampsia?

If our hypothesis is confirmed, it will allow differentiation of PPE and SPE sooner than 12 weeks postpartum, which is currently the estimated period for confirmation of the specific diagnosis. Furthermore, it could be an early biomarker for predicting the disease, enabling the physician to choose the best clinical management. In addition, it would minimize the use of other methods as the biological sample for obtaining the marker is urine, a practical and effective test with good reproducibility. Finally, test results would enable a greater understanding of the mechanisms involved in gestational hypertension.